ArticleThe journal of sexual medicine2014
Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.
Article in The journal of sexual medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option.The Journal of clinical endocrinology and metabolism · 2022Pooled it
- Update on testosterone deficiency and therapeutic options for testosterone replacement therapy.Nature reviews. Urology · 2026Review
- Alternatives to serum testing for transdermal testosterone monitoring: a review of clinical data and correlation with clinical response.Frontiers in reproductive health · 2026Article
- A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men.Translational andrology and urology · 2025Article
- Article
- Testosterone replacement therapy is associated with high satisfaction rates: results of a survey study.International journal of impotence research · 2024Article
- Prevalence of secondary erythrocytosis in men receiving testosterone therapy A matched-cohort analysis of intranasal gel, injections, and pellets.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023Article
- Trends in testosterone prescription amongst medical specialties: a 5-year CMS data analysis.International journal of impotence research · 2023Article
- The Pre-Testosterone Therapy Checklist.The journal of sexual medicine · 2022Article
- Testosterone Replacement Therapy in the Aged Male: Monitoring Patients' Quality of Life Utilizing Scoring Systems.International journal of general medicine · 2022Review
- A cross-sectional comparison of secondary polycythemia in testosterone-deficient men treated with nasal testosterone gel vs. intramuscular testosterone cypionate.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021Article
- The My-T study: Patient satisfaction and preference comparing topical and nasal testosterone therapies.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2019Article
- A Pilot Study Using a Web Survey to Identify Characteristics That Influence Hypogonadal Men to Initiate Testosterone Replacement Therapy.American journal of men's health · 2018Article
- Erythrocytosis Following Testosterone Therapy.Sexual medicine reviews · 2018Review
- Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone.Journal of the Endocrine Society · 2017Article
- Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study.Sexual medicine · 2015Article
- Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen.Sexual medicine · 2015Article
- Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age?Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2014Article
- Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.Postgraduate medicine · 2014Review
- The importance of understanding baseline reproductive function prior to the administration of exogenous testosterone.Asian journal of andrologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionTestosterone replacement therapy (TRT) for male hypogonadism is rapidly gaining popularity and acceptance. Options include gels, injections, and implantable subcutaneous pellets.
aimsThe aim of this study was to determine rates of patient satisfaction and reasons for patient preferences in hypogonadal men on TRT.
methodsAn anonymous, prospective survey was distributed to men presenting for TRT at an academic urology clinic. The survey was organized into multiple domains including patient satisfaction and treatment motivation.
main outcome measuresPatient satisfaction responses obtained via anonymous survey.
resultsAverage patient age was 49 ± 0.7 years (n = 382). Injectable testosterone was chosen by 53%, gel-based regimens by 31%, and pellets by 17%. Overall, 70% of patients were satisfied with their TRT and 14% reported dissatisfaction. Satisfaction rates were similar between gels (68%), injections (73%), and implantable pellets (70%). Doctor recommendation was the sole significant reason for patients preferring gel-based TRT (66% vs. 37% injection users vs. 31% pellet users). Injectable TRT was favored because of lower cost (35% vs. 21% gel users vs. 19% pellet users). Pellets were favored for ease of use (64% vs. 44% injection users vs. 43% gel users) and convenience (58% vs. 26% injection users vs. 19% gel users). Pellets had increased rates of satisfaction within the first 12 months. Improvements in concentration and mood occurred at higher percentages in satisfied patients.
conclusionsPatients are satisfied with TRT. Lower costs are important to patients on injections. Convenience and ease of use are central in choosing pellet therapy. Men on TRT should be questioned about mood and concentration because these factors exhibited the greatest improvements in satisfied patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.